Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers

Nature Nanotechnology

Volumn 10, Issue 4, 2015, Pages 370-379

  Kotagiri, Nalinikanth ^a   Sudlow, Gail P ^a   Akers, Walter J ^a   Achilefu, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; CERENKOV COUNTERS; FREE RADICALS; MAMMALS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; RADIOISOTOPES; TIO2 NANOPARTICLES; TITANIUM DIOXIDE;

CANCEROUS CELLS; CERENKOV RADIATION; COLOCALIZATION; HISTOLOGICAL ANALYSIS; MEDIAN SURVIVAL; SELECTIVE DESTRUCTION; TISSUE OXYGENATION; TITANIUM DIOXIDES (TIO2);

TUMORS;

FREE RADICAL; NANOCOATING; PHOTOSENSITIZING AGENT; RADIOISOTOPE; TITANIUM DIOXIDE; TRANSFERRIN; METAL NANOPARTICLE; TITANIUM;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL DESTRUCTION; CERENKOV RADIATION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYMPHOCYTE; MOUSE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION; SYNTHESIS; TUMOR REGRESSION; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ELECTROMAGNETISM; FEMALE; HUMAN; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; PARTICLE SIZE; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION ABSORPTION; RADIATION DOSE; RADIATION RESPONSE; RADIATION SCATTERING; TUMOR CELL LINE; ULTRASTRUCTURE;

ABSORPTION, RADIATION; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; METAL NANOPARTICLES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIATION DOSAGE; SCATTERING, RADIATION; TITANIUM;

EID: 84927168282     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2015.17     Document Type: Article

References (36)

1. Ethirajan, M., Chen, Y., Joshi, P. & Pandey, R. K. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem. Soc. Rev. 40, 340-362 (2011).
2. Spring, B. Q. et al. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc. Natl Acad. Sci. USA 111, E993-E492 (2014).
3. Jelley, J. V. Cerenkov radiation and its applications. Br. J. Appl. Phys. 6, 227-232 (1955).
4. Robertson, R. et al. Optical imaging of Cerenkov light generation from positronemitting radiotracers. Phys. Med. Biol. 54, N355 (2009).
5. Cherry, S. & Dahlbom, M. in PET (ed. Phelps, M.) 1-117 (Springer, 2006).
6. Liu, H. et al. Molecular optical imaging with radioactive probes. PLoS ONE 5, e9470 (2010).
7. Spinelli, A. E. et al. Multispectral Cerenkov luminescence tomography for small animal optical imaging. Opt. Express 19, 12605-12618 (2011).
8. Kotagiri, N., Niedzwiedzki, D. M., Ohara, K. & Achilefu, S. Activatable probes based on distance-dependent luminescence associated with Cerenkov radiation. Angew. Chem. Int. Ed. 52, 7756-7760 (2013).
9. Sun, X. et al. Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J. Am. Chem. Soc. 136, 1706-1709 (2014).
10. Axelsson, J., Davis, S. C., Gladstone, D. J. & Pogue, B. W. Cerenkov emission induced by external beam radiation stimulates molecular fluorescence. Med. Phys. 38, 4127-4132 (2011).
11. Spinelli, A. E. et al. First human Cerenkography. J. Biomed. Opt. 18, 20502 (2013).
12. Thorek, D. L., Ogirala, A., Beattie, B. J. & Grimm, J. Quantitative imaging of disease signatures through radioactive decay signal conversion. Nature Med. 19, 1345-1350 (2013).
13. Linsebigler, A., Lu, G. & Yates, J. Photocatalysis on TiOn surfaces: principles, mechanisms, and selected results. Chem. Rev. 95, 735-758 (1995).
14. Schwarz, P. F. et al. A new method to determine the generation of hydroxyl radicals in illuminated TiO2 suspensions. J. Phys. Chem. B 101, 7127-7134 (1997).
15. Boehm, H. P. Acidic and basic properties of hydroxylated metal oxide surfaces. Discuss. Faraday Soc. 52, 264-275 (1971).
16. Mitchell, G. S., Gill, R. K., Boucher, D. L., Li, C. & Cherry, S. R. In vivo Cerenkov luminescence imaging: a new tool for molecular imaging. Philos. Trans. A 369, 4605-4619 (2011).
17. Huang,W., Lei, M., Huang, H., Chen, J. & Chen, H. Effect of polyethylene glycol on hydrophilic TiO2 films: porosity-driven superhydrophilicity. Surf. Coat. Technol. 204, 3954-3961 (2010).
18. Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E. & Mason, D. Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol. 36, 539-545 (1983).
19. Ji, Z. et al. Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ. Sci. Technol. 44, 7309-7314 (2010).
20. Bowman, D. C. The amazingly versatile titanocene derivatives. J. Chem. Educ. 83, 735 (2006).
21. Clearfield, A., Warner, D. K., Saldarriaga-Molina, C. H., Ropal, R. & Bernal, I. Structural studies of (C5H5)2MX2 complexes and their derivatives. The structure of bis(cyclopentadienyl)titanium dichloride. Can. J. Chem. 53, 1622-1629 (1975).
22. Lümmen, G., Sperling, H., Luboldt, H., Otto, T. & Rübben, H. Phase II trial of titanocene dichloride in advanced renal-cell carcinoma. Cancer Chemother. Pharmacol. 42, 415-417 (1998).
23. Kröger, N., Kleeberg, U. R., Mross, K., Edler, L. & Hossfeld, D. K. Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer. Oncol. Res. Treat. 23, 60-62 (2000).
24. Davidenko, N., Garcia, O. & Sastre, R. The efficiency of titanocene as photoinitiator in the polymerization of dental formulations. J. Biomater. Sci. Polym. Ed. 14, 733-746 (2003).
25. Tehfe, M-A., Lalevée, J., Morlet-Savary, F., Graff, B. & Fouassier, J-P. On the use of bis(cyclopentadienyl)titanium(IV) dichloride in visible-light-induced ringopening photopolymerization. Macromolecules 45, 356-361 (2011).
26. Brindley, P. B., Davies, A. G. & Hawari, J. A. A. An ESR study of the photolysis of dicyclopentadienyltitanium dichloride. J. Organomet. Chem. 250, 247-256 (1983).
27. Qian, Z. M., Li, H., Sun, H. & Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561-587 (2002).
28. Tijana, R., Nada, M. D., Adam, E. & Elena, R. in Handbook of Nanophysics 1-28 (CRC Press, 2010).
29. Paunesku, T. et al. Biology of TiO2-oligonucleotide nanocomposites. Nature Mater. 2, 343-346 (2003).
30. Zhao, J. et al. Titanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid and mitochondrial pathways. J. Toxicol. Environ. Health A 72, 1141-1149 (2009).
31. O'Connor, K. et al. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells. Apoptosis 11, 1205-1214 (2006).
32. Kelloff, G. J. et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11, 2785-2808 (2005).
33. Heyne, B., Maurel, V. & Scaiano, J. C. Mechanism of action of sensors for reactive oxygen species based on fluorescein-phenol coupling: the case of 2-[6- (4hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid. Org. Biomol. Chem. 4, 802-807 (2006).
34. Rozhkova, E. A. et al. A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett. 9, 3337-3342 (2009).
35. Misra, R. M., Bajaj, M. S. & Kale, V. P. Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1neuropilin-1 axis. PLoS ONE 7, 21 (2012).
36. Dautry-Varsat, A., Ciechanover, A. & Lodish, H. F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 80, 2258-2262 (1983).